Structure

Physi-Chem Properties

Molecular Weight:  460.19
Volume:  434.886
LogP:  -0.537
LogD:  -0.794
LogS:  -1.791
# Rotatable Bonds:  9
TPSA:  178.53
# H-Bond Aceptor:  11
# H-Bond Donor:  7
# Rings:  3
# Heavy Atoms:  11

MedChem Properties

QED Drug-Likeness Score:  0.217
Synthetic Accessibility Score:  4.341
Fsp3:  0.714
Lipinski Rule-of-5:  Rejected
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  0
Golden Triangle Rule:  Accepted
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -6.274
MDCK Permeability:  5.095778396935202e-05
Pgp-inhibitor:  0.002
Pgp-substrate:  0.846
Human Intestinal Absorption (HIA):  0.929
20% Bioavailability (F20%):  0.99
30% Bioavailability (F30%):  1.0

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.128
Plasma Protein Binding (PPB):  60.73296356201172%
Volume Distribution (VD):  0.289
Pgp-substrate:  27.145217895507812%

ADMET: Metabolism

CYP1A2-inhibitor:  0.024
CYP1A2-substrate:  0.026
CYP2C19-inhibitor:  0.028
CYP2C19-substrate:  0.294
CYP2C9-inhibitor:  0.002
CYP2C9-substrate:  0.082
CYP2D6-inhibitor:  0.007
CYP2D6-substrate:  0.134
CYP3A4-inhibitor:  0.008
CYP3A4-substrate:  0.05

ADMET: Excretion

Clearance (CL):  1.145
Half-life (T1/2):  0.774

ADMET: Toxicity

hERG Blockers:  0.209
Human Hepatotoxicity (H-HT):  0.076
Drug-inuced Liver Injury (DILI):  0.046
AMES Toxicity:  0.527
Rat Oral Acute Toxicity:  0.235
Maximum Recommended Daily Dose:  0.003
Skin Sensitization:  0.908
Carcinogencity:  0.071
Eye Corrosion:  0.003
Eye Irritation:  0.128
Respiratory Toxicity:  0.022

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC469702

Natural Product ID:  NPC469702
Common Name*:   2-(3,4-Dihydroxy-5-Hydroxymethyl-Tetrahydro-Furan-2-Yloxymethyl)-6-[3-(4-Hydroxy-Phenyl)-1-Methyl-Propoxy]-Tetrahydro-Pyran-3,4,5-Triol
IUPAC Name:   (2R,3R,4R,5R,6R)-2-[[(2R,3S,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxymethyl]-6-[(2R)-4-(4-hydroxyphenyl)butan-2-yl]oxyoxane-3,4,5-triol
Synonyms:  
Standard InCHIKey:  DJDISCKFJXDADJ-LCIFOZHJSA-N
Standard InCHI:  InChI=1S/C21H32O11/c1-10(2-3-11-4-6-12(23)7-5-11)30-21-19(28)17(26)16(25)14(32-21)9-29-20-18(27)15(24)13(8-22)31-20/h4-7,10,13-28H,2-3,8-9H2,1H3/t10-,13-,14-,15-,16+,17-,18+,19-,20-,21-/m1/s1
SMILES:  CC(CCC1=CC=C(C=C1)O)OC2C(C(C(C(O2)COC3C(C(C(O3)CO)O)O)O)O)O
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL1159482
PubChem CID:   46905136
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000012] Lipids and lipid-like molecules
      • [CHEMONTID:0003909] Fatty Acyls
        • [CHEMONTID:0001766] Fatty acyl glycosides
          • [CHEMONTID:0003861] Fatty acyl glycosides of mono- and disaccharides

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO4138.1 Betula platyphylla var. japonica Varieties Betulaceae Eukaryota floral spikes n.a. n.a. PMID[17346076]
NPO4138.1 Betula platyphylla var. japonica Varieties Betulaceae Eukaryota bark n.a. n.a. PMID[9873651]
NPO4138.1 Betula platyphylla var. japonica Varieties Betulaceae Eukaryota n.a. n.a. n.a. Database[HerDing]
NPO4138.1 Betula platyphylla var. japonica Varieties Betulaceae Eukaryota n.a. n.a. n.a. Database[TCMID]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT29 Organism Rattus norvegicus Rattus norvegicus Inhibition = 3.4 % PMID[557078]
NPT29 Organism Rattus norvegicus Rattus norvegicus Inhibition = 6.2 % PMID[557078]
NPT29 Organism Rattus norvegicus Rattus norvegicus Inhibition = 7.5 % PMID[557078]
NPT29 Organism Rattus norvegicus Rattus norvegicus Inhibition = 6.8 % PMID[557078]
NPT29 Organism Rattus norvegicus Rattus norvegicus Inhibition = 5.1 % PMID[557078]
NPT29 Organism Rattus norvegicus Rattus norvegicus Inhibition = 98.2 % PMID[557078]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC469702 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
1.0 High Similarity NPC282409
0.9912 High Similarity NPC476448
0.9912 High Similarity NPC469548
0.9912 High Similarity NPC476445
0.9643 High Similarity NPC148055
0.9569 High Similarity NPC471067
0.9487 High Similarity NPC178449
0.9487 High Similarity NPC470907
0.9487 High Similarity NPC232454
0.9483 High Similarity NPC55608
0.9464 High Similarity NPC157338
0.9397 High Similarity NPC469704
0.9397 High Similarity NPC201402
0.9397 High Similarity NPC160854
0.9397 High Similarity NPC469703
0.9316 High Similarity NPC469686
0.9174 High Similarity NPC469687
0.9167 High Similarity NPC90318
0.913 High Similarity NPC175771
0.9123 High Similarity NPC313193
0.9016 High Similarity NPC35288
0.9016 High Similarity NPC471881
0.9016 High Similarity NPC45224
0.9016 High Similarity NPC156692
0.9016 High Similarity NPC173150
0.9016 High Similarity NPC471882
0.8992 High Similarity NPC266045
0.8934 High Similarity NPC61181
0.888 High Similarity NPC478255
0.8871 High Similarity NPC469549
0.8862 High Similarity NPC264900
0.8862 High Similarity NPC108659
0.8862 High Similarity NPC79715
0.8862 High Similarity NPC231607
0.8862 High Similarity NPC103533
0.881 High Similarity NPC471095
0.881 High Similarity NPC471066
0.879 High Similarity NPC225307
0.878 High Similarity NPC94179
0.877 High Similarity NPC287429
0.876 High Similarity NPC476142
0.876 High Similarity NPC52097
0.874 High Similarity NPC164172
0.873 High Similarity NPC235294
0.873 High Similarity NPC46137
0.872 High Similarity NPC184092
0.871 High Similarity NPC106677
0.871 High Similarity NPC288416
0.8689 High Similarity NPC212176
0.8678 High Similarity NPC11724
0.8672 High Similarity NPC470881
0.8651 High Similarity NPC17968
0.8651 High Similarity NPC469705
0.8651 High Similarity NPC470122
0.864 High Similarity NPC148982
0.8629 High Similarity NPC471157
0.8595 High Similarity NPC198734
0.8595 High Similarity NPC476872
0.8595 High Similarity NPC269242
0.8595 High Similarity NPC469412
0.8594 High Similarity NPC6836
0.8583 High Similarity NPC138777
0.8583 High Similarity NPC65942
0.8583 High Similarity NPC246869
0.8583 High Similarity NPC281798
0.8583 High Similarity NPC225384
0.8583 High Similarity NPC248307
0.8548 High Similarity NPC126991
0.8548 High Similarity NPC470510
0.8548 High Similarity NPC83218
0.8527 High Similarity NPC471883
0.8527 High Similarity NPC169398
0.8527 High Similarity NPC35731
0.8516 High Similarity NPC252833
0.8516 High Similarity NPC254275
0.8512 High Similarity NPC60589
0.8512 High Similarity NPC469708
0.8492 Intermediate Similarity NPC158673
0.8487 Intermediate Similarity NPC301651
0.8487 Intermediate Similarity NPC473556
0.848 Intermediate Similarity NPC252114
0.8473 Intermediate Similarity NPC469696
0.8462 Intermediate Similarity NPC263829
0.845 Intermediate Similarity NPC254398
0.845 Intermediate Similarity NPC25821
0.845 Intermediate Similarity NPC28637
0.8448 Intermediate Similarity NPC264784
0.8438 Intermediate Similarity NPC475824
0.8438 Intermediate Similarity NPC219677
0.8425 Intermediate Similarity NPC307110
0.8421 Intermediate Similarity NPC472711
0.8409 Intermediate Similarity NPC328273
0.8409 Intermediate Similarity NPC321184
0.8409 Intermediate Similarity NPC321638
0.8409 Intermediate Similarity NPC171134
0.8407 Intermediate Similarity NPC47286
0.84 Intermediate Similarity NPC123704
0.8397 Intermediate Similarity NPC52277
0.8397 Intermediate Similarity NPC177035
0.8397 Intermediate Similarity NPC199459
0.8372 Intermediate Similarity NPC473924
0.8359 Intermediate Similarity NPC472024
0.8359 Intermediate Similarity NPC80600
0.8333 Intermediate Similarity NPC469364
0.8333 Intermediate Similarity NPC470413
0.8333 Intermediate Similarity NPC101686
0.8333 Intermediate Similarity NPC304152
0.8333 Intermediate Similarity NPC138738
0.8333 Intermediate Similarity NPC65262
0.8333 Intermediate Similarity NPC195196
0.8296 Intermediate Similarity NPC477898
0.8296 Intermediate Similarity NPC185307
0.8296 Intermediate Similarity NPC46092
0.8296 Intermediate Similarity NPC470950
0.8295 Intermediate Similarity NPC254819
0.8295 Intermediate Similarity NPC476407
0.8291 Intermediate Similarity NPC30563
0.8281 Intermediate Similarity NPC248355
0.8281 Intermediate Similarity NPC26653
0.8281 Intermediate Similarity NPC166040
0.8281 Intermediate Similarity NPC270849
0.8281 Intermediate Similarity NPC229784
0.8281 Intermediate Similarity NPC253595
0.8281 Intermediate Similarity NPC97326
0.8281 Intermediate Similarity NPC477293
0.8281 Intermediate Similarity NPC477294
0.8279 Intermediate Similarity NPC477803
0.8271 Intermediate Similarity NPC472350
0.8271 Intermediate Similarity NPC197316
0.8271 Intermediate Similarity NPC81515
0.8271 Intermediate Similarity NPC476383
0.8271 Intermediate Similarity NPC89105
0.8271 Intermediate Similarity NPC64141
0.8271 Intermediate Similarity NPC68092
0.8264 Intermediate Similarity NPC476266
0.8244 Intermediate Similarity NPC886
0.8244 Intermediate Similarity NPC187194
0.8244 Intermediate Similarity NPC107478
0.8244 Intermediate Similarity NPC287597
0.8244 Intermediate Similarity NPC34293
0.8235 Intermediate Similarity NPC296954
0.8235 Intermediate Similarity NPC141455
0.8235 Intermediate Similarity NPC129417
0.8235 Intermediate Similarity NPC84181
0.8235 Intermediate Similarity NPC470235
0.8235 Intermediate Similarity NPC283995
0.8235 Intermediate Similarity NPC300894
0.8235 Intermediate Similarity NPC196063
0.8231 Intermediate Similarity NPC473285
0.8226 Intermediate Similarity NPC226712
0.8222 Intermediate Similarity NPC476356
0.8217 Intermediate Similarity NPC262606
0.8217 Intermediate Similarity NPC474491
0.8205 Intermediate Similarity NPC474148
0.8205 Intermediate Similarity NPC276061
0.8203 Intermediate Similarity NPC302378
0.8203 Intermediate Similarity NPC232880
0.8195 Intermediate Similarity NPC476376
0.8195 Intermediate Similarity NPC260425
0.8195 Intermediate Similarity NPC87777
0.8195 Intermediate Similarity NPC262328
0.8182 Intermediate Similarity NPC184938
0.8182 Intermediate Similarity NPC101624
0.8182 Intermediate Similarity NPC79957
0.8182 Intermediate Similarity NPC123988
0.8175 Intermediate Similarity NPC22150
0.8175 Intermediate Similarity NPC38041
0.8175 Intermediate Similarity NPC279298
0.8175 Intermediate Similarity NPC18979
0.8174 Intermediate Similarity NPC152384
0.8174 Intermediate Similarity NPC37714
0.8168 Intermediate Similarity NPC294166
0.8168 Intermediate Similarity NPC132895
0.8168 Intermediate Similarity NPC115022
0.8162 Intermediate Similarity NPC105005
0.8162 Intermediate Similarity NPC40305
0.8162 Intermediate Similarity NPC478250
0.8154 Intermediate Similarity NPC9912
0.8154 Intermediate Similarity NPC475067
0.8151 Intermediate Similarity NPC290353
0.8151 Intermediate Similarity NPC153795
0.8151 Intermediate Similarity NPC42911
0.8148 Intermediate Similarity NPC476377
0.8148 Intermediate Similarity NPC47471
0.8148 Intermediate Similarity NPC134405
0.8148 Intermediate Similarity NPC476385
0.814 Intermediate Similarity NPC295970
0.8134 Intermediate Similarity NPC205195
0.8134 Intermediate Similarity NPC49597
0.8134 Intermediate Similarity NPC220942
0.8134 Intermediate Similarity NPC226005
0.8134 Intermediate Similarity NPC156376
0.8125 Intermediate Similarity NPC262826
0.8125 Intermediate Similarity NPC198798
0.8125 Intermediate Similarity NPC476873
0.812 Intermediate Similarity NPC470572
0.812 Intermediate Similarity NPC471345
0.812 Intermediate Similarity NPC165482
0.812 Intermediate Similarity NPC138350
0.812 Intermediate Similarity NPC3293

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC469702 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.8271 Intermediate Similarity NPD7266 Discontinued
0.8226 Intermediate Similarity NPD1091 Approved
0.7638 Intermediate Similarity NPD5126 Approved
0.7638 Intermediate Similarity NPD5125 Phase 3
0.7561 Intermediate Similarity NPD7843 Approved
0.7544 Intermediate Similarity NPD2934 Approved
0.7544 Intermediate Similarity NPD2933 Approved
0.7519 Intermediate Similarity NPD3705 Approved
0.7478 Intermediate Similarity NPD2859 Approved
0.7478 Intermediate Similarity NPD2860 Approved
0.7465 Intermediate Similarity NPD5058 Phase 3
0.7463 Intermediate Similarity NPD3027 Phase 3
0.7422 Intermediate Similarity NPD1357 Approved
0.7381 Intermediate Similarity NPD7157 Approved
0.7377 Intermediate Similarity NPD2684 Approved
0.7311 Intermediate Similarity NPD846 Approved
0.7311 Intermediate Similarity NPD940 Approved
0.7293 Intermediate Similarity NPD3094 Phase 2
0.7288 Intermediate Similarity NPD3020 Approved
0.7211 Intermediate Similarity NPD1653 Approved
0.72 Intermediate Similarity NPD969 Suspended
0.7177 Intermediate Similarity NPD3022 Approved
0.7177 Intermediate Similarity NPD3021 Approved
0.7174 Intermediate Similarity NPD1612 Clinical (unspecified phase)
0.7174 Intermediate Similarity NPD1613 Approved
0.7154 Intermediate Similarity NPD290 Approved
0.7143 Intermediate Similarity NPD4978 Clinical (unspecified phase)
0.7133 Intermediate Similarity NPD6674 Discontinued
0.7121 Intermediate Similarity NPD3092 Approved
0.7099 Intermediate Similarity NPD5238 Clinical (unspecified phase)
0.7094 Intermediate Similarity NPD1432 Clinical (unspecified phase)
0.7092 Intermediate Similarity NPD5588 Approved
0.7086 Intermediate Similarity NPD8455 Phase 2
0.7059 Intermediate Similarity NPD4381 Clinical (unspecified phase)
0.7059 Intermediate Similarity NPD2861 Phase 2
0.7054 Intermediate Similarity NPD111 Approved
0.704 Intermediate Similarity NPD9380 Clinical (unspecified phase)
0.7025 Intermediate Similarity NPD7228 Approved
0.7021 Intermediate Similarity NPD4536 Approved
0.7021 Intermediate Similarity NPD4538 Approved
0.7021 Intermediate Similarity NPD4537 Clinical (unspecified phase)
0.7021 Intermediate Similarity NPD7097 Phase 1
0.7007 Intermediate Similarity NPD4908 Phase 1
0.6963 Remote Similarity NPD8651 Approved
0.6947 Remote Similarity NPD3091 Approved
0.6947 Remote Similarity NPD1548 Phase 1
0.6942 Remote Similarity NPD3028 Approved
0.6942 Remote Similarity NPD1242 Phase 1
0.6929 Remote Similarity NPD228 Approved
0.6918 Remote Similarity NPD6190 Approved
0.6908 Remote Similarity NPD37 Approved
0.6906 Remote Similarity NPD4907 Clinical (unspecified phase)
0.6903 Remote Similarity NPD6234 Discontinued
0.6897 Remote Similarity NPD1652 Phase 2
0.6889 Remote Similarity NPD3685 Discontinued
0.6889 Remote Similarity NPD4659 Approved
0.6884 Remote Similarity NPD1529 Clinical (unspecified phase)
0.6883 Remote Similarity NPD4967 Phase 2
0.6883 Remote Similarity NPD4965 Approved
0.6883 Remote Similarity NPD4966 Approved
0.6875 Remote Similarity NPD7054 Approved
0.6875 Remote Similarity NPD7804 Clinical (unspecified phase)
0.687 Remote Similarity NPD856 Approved
0.687 Remote Similarity NPD16 Approved
0.6866 Remote Similarity NPD1610 Phase 2
0.6863 Remote Similarity NPD2978 Approved
0.6863 Remote Similarity NPD2977 Approved
0.6857 Remote Similarity NPD6405 Approved
0.6857 Remote Similarity NPD6233 Phase 2
0.6857 Remote Similarity NPD6407 Approved
0.6853 Remote Similarity NPD5960 Phase 3
0.6852 Remote Similarity NPD6559 Discontinued
0.6846 Remote Similarity NPD6671 Approved
0.6842 Remote Similarity NPD9381 Approved
0.6842 Remote Similarity NPD9384 Approved
0.6832 Remote Similarity NPD7074 Phase 3
0.6832 Remote Similarity NPD7472 Approved
0.6831 Remote Similarity NPD6653 Approved
0.6824 Remote Similarity NPD6143 Clinical (unspecified phase)
0.6822 Remote Similarity NPD7159 Clinical (unspecified phase)
0.6818 Remote Similarity NPD9545 Approved
0.6815 Remote Similarity NPD2561 Approved
0.6815 Remote Similarity NPD2562 Approved
0.6813 Remote Similarity NPD3818 Discontinued
0.6812 Remote Similarity NPD1530 Clinical (unspecified phase)
0.6812 Remote Similarity NPD5736 Approved
0.68 Remote Similarity NPD968 Approved
0.6797 Remote Similarity NPD6124 Clinical (unspecified phase)
0.6788 Remote Similarity NPD4103 Phase 2
0.6788 Remote Similarity NPD4104 Clinical (unspecified phase)
0.6786 Remote Similarity NPD6859 Clinical (unspecified phase)
0.6781 Remote Similarity NPD5698 Clinical (unspecified phase)
0.6772 Remote Similarity NPD4750 Phase 3
0.6765 Remote Similarity NPD9622 Approved
0.6761 Remote Similarity NPD6355 Discontinued
0.675 Remote Similarity NPD1809 Phase 2
0.675 Remote Similarity NPD844 Approved
0.6748 Remote Similarity NPD7685 Pre-registration
0.6748 Remote Similarity NPD7251 Discontinued
0.6746 Remote Similarity NPD1358 Approved
0.6742 Remote Similarity NPD318 Approved
0.6742 Remote Similarity NPD317 Approved
0.6741 Remote Similarity NPD422 Phase 1
0.6735 Remote Similarity NPD4628 Phase 3
0.6723 Remote Similarity NPD845 Approved
0.6716 Remote Similarity NPD3095 Discontinued
0.6716 Remote Similarity NPD5846 Approved
0.6716 Remote Similarity NPD6516 Phase 2
0.6714 Remote Similarity NPD3180 Approved
0.6714 Remote Similarity NPD3179 Approved
0.6713 Remote Similarity NPD5314 Approved
0.6712 Remote Similarity NPD2424 Discontinued
0.6707 Remote Similarity NPD7808 Phase 3
0.6692 Remote Similarity NPD7741 Discontinued
0.669 Remote Similarity NPD3062 Approved
0.669 Remote Similarity NPD4060 Phase 1
0.669 Remote Similarity NPD3059 Approved
0.669 Remote Similarity NPD7966 Clinical (unspecified phase)
0.669 Remote Similarity NPD3061 Approved
0.6687 Remote Similarity NPD6797 Phase 2
0.6667 Remote Similarity NPD4236 Phase 3
0.6667 Remote Similarity NPD4237 Approved
0.6667 Remote Similarity NPD4380 Phase 2
0.6667 Remote Similarity NPD289 Clinical (unspecified phase)
0.6667 Remote Similarity NPD6410 Clinical (unspecified phase)
0.6667 Remote Similarity NPD6798 Discontinued
0.6646 Remote Similarity NPD7240 Approved
0.6644 Remote Similarity NPD5762 Approved
0.6644 Remote Similarity NPD2029 Clinical (unspecified phase)
0.6644 Remote Similarity NPD5763 Approved
0.6643 Remote Similarity NPD4340 Discontinued
0.6643 Remote Similarity NPD5124 Phase 1
0.6643 Remote Similarity NPD5735 Approved
0.6643 Remote Similarity NPD5123 Clinical (unspecified phase)
0.6621 Remote Similarity NPD4108 Discontinued
0.6621 Remote Similarity NPD7033 Discontinued
0.662 Remote Similarity NPD6663 Approved
0.662 Remote Similarity NPD4062 Phase 3
0.6619 Remote Similarity NPD9619 Approved
0.6619 Remote Similarity NPD9621 Approved
0.6619 Remote Similarity NPD9620 Approved
0.6618 Remote Similarity NPD5351 Clinical (unspecified phase)
0.6618 Remote Similarity NPD5350 Clinical (unspecified phase)
0.6615 Remote Similarity NPD821 Approved
0.6604 Remote Similarity NPD7199 Phase 2
0.6597 Remote Similarity NPD2568 Approved
0.6589 Remote Similarity NPD9280 Clinical (unspecified phase)
0.6573 Remote Similarity NPD3620 Phase 2
0.6573 Remote Similarity NPD3619 Clinical (unspecified phase)
0.6565 Remote Similarity NPD2229 Approved
0.6565 Remote Similarity NPD2228 Approved
0.6565 Remote Similarity NPD2234 Approved
0.6565 Remote Similarity NPD5283 Phase 1
0.6557 Remote Similarity NPD288 Approved
0.6556 Remote Similarity NPD3536 Discontinued
0.6556 Remote Similarity NPD8389 Clinical (unspecified phase)
0.6549 Remote Similarity NPD598 Approved
0.6549 Remote Similarity NPD3764 Approved
0.6549 Remote Similarity NPD597 Approved
0.6549 Remote Similarity NPD601 Approved
0.6547 Remote Similarity NPD1134 Approved
0.6547 Remote Similarity NPD1131 Approved
0.6547 Remote Similarity NPD1129 Approved
0.6547 Remote Similarity NPD1133 Approved
0.6547 Remote Similarity NPD1135 Approved
0.6547 Remote Similarity NPD6362 Approved
0.6547 Remote Similarity NPD4339 Clinical (unspecified phase)
0.6541 Remote Similarity NPD694 Clinical (unspecified phase)
0.6538 Remote Similarity NPD5773 Approved
0.6538 Remote Similarity NPD5772 Approved
0.6535 Remote Similarity NPD3134 Approved
0.6531 Remote Similarity NPD1375 Discontinued
0.6531 Remote Similarity NPD6002 Phase 3
0.6531 Remote Similarity NPD6006 Clinical (unspecified phase)
0.6531 Remote Similarity NPD6005 Phase 3
0.6531 Remote Similarity NPD6003 Clinical (unspecified phase)
0.6531 Remote Similarity NPD6004 Phase 3
0.6528 Remote Similarity NPD230 Phase 1
0.6522 Remote Similarity NPD6583 Phase 3
0.6522 Remote Similarity NPD4379 Clinical (unspecified phase)
0.6522 Remote Similarity NPD6582 Phase 2
0.6522 Remote Similarity NPD2983 Phase 2
0.6522 Remote Similarity NPD2982 Phase 2
0.6522 Remote Similarity NPD4749 Approved
0.6519 Remote Similarity NPD7075 Discontinued
0.6515 Remote Similarity NPD9614 Approved
0.6515 Remote Similarity NPD9618 Approved
0.6515 Remote Similarity NPD2629 Approved
0.651 Remote Similarity NPD4535 Phase 3
0.6508 Remote Similarity NPD9608 Approved
0.6508 Remote Similarity NPD9610 Approved
0.6506 Remote Similarity NPD4338 Clinical (unspecified phase)
0.6503 Remote Similarity NPD1130 Approved
0.6503 Remote Similarity NPD1132 Approved
0.6503 Remote Similarity NPD1136 Approved
0.65 Remote Similarity NPD6917 Clinical (unspecified phase)
0.65 Remote Similarity NPD6007 Clinical (unspecified phase)
0.65 Remote Similarity NPD5647 Approved
0.6489 Remote Similarity NPD7635 Approved
0.6489 Remote Similarity NPD5535 Approved

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data